Senior insider sale
SVP, General Counsel at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$40.2K
22.90K shares
What this filing means
DOUGLAS EARL MARTIN plans to sell 22.90K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $40.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001950047-26-000851
Officer· SVP, General Counsel
Since Feb 2026
22.90K
Shares to sell
$40.2K
Approx. market value
22.90K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
1/31/2026
22.90KTotal acquired22.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted stock vesting under a registered plan Compensation | 22.90K | — |
| Total | 22.90K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
22.90K
Market value
$40.2K
2/2/2026
Total
Units
22.90K
Value
$40.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2026 | 22.90K | $40.2K | NASDAQ | Planned |
| Total | 22.90K | $40.2K | ||